KDAG.F Stock Overview

Provides technological solutions to general and specialized health sectors in Canada. More details

KDAG.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Risk Analysis

Makes less than USD$1m in revenue (CA$215K)

Earnings have declined by 4.2% per year over past 5 years

Has less than 1 year of cash runway

Shares are highly illiquid

+ 1 more risk

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

KDA Group Inc. Competitors

Pheton Holdings

NasdaqCM:PTHL

US$54.9m

DarioHealth

NasdaqCM:DRIO

US$30.0m

iCAD

NasdaqCM:ICAD

US$93.0m

CareCloud

NasdaqGM:CCLD

US$79.8m

Price History & Performance

Summary of share price highs, lows and changes for KDA Group
Historical stock prices
Current Share Price	CA$0.19
52 Week High	CA$0.28
52 Week Low	CA$0.15
Beta	1.45
1 Month Change	9.54%
3 Month Change	1.01%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	35.36%

Recent updates

Shareholder Returns

	KDAG.F	US Healthcare Services	US Market
7D	9.5%	3.8%	2.9%
1Y	n/a	10.6%	10.0%

Return vs Industry: Insufficient data to determine how KDAG.F performed against the US Healthcare Services industry.

Return vs Market: Insufficient data to determine how KDAG.F performed against the US Market.

Price Volatility

Is KDAG.F's price volatile compared to industry and market?
KDAG.F volatility
KDAG.F Average Weekly Movement	n/a
Healthcare Services Industry Average Movement	11.6%
Market Average Movement	7.8%
10% most volatile stocks in US Market	16.2%
10% least volatile stocks in US Market	4.1%

Stable Share Price: KDAG.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine KDAG.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Marc Lemieux	groupkda.com

KDA Group Inc., together with its subsidiaries, provides technological solutions to general and specialized health sectors in Canada. It offers Prescripteur KRx, an electronic prescription platform assisting dentists in practice; KRx Cannabinoid, an electronic prescription platform helping doctors in practice for prescribing medical cannabis; Adherize (ADRX), a suite of virtual resources to present and share crucial information for doctors and pharmacists, as well as a patient portal allows easy access to personalized information; and Medherize, a platform for clinical management of patients requiring specialized medication. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017.

KDA Group Inc. Fundamentals Summary

How do KDA Group's earnings and revenue compare to its market cap?
KDAG.F fundamental statistics
Market cap	US$36.11m
Earnings (TTM)	-US$5.98m
Revenue (TTM)	US$155.87k

231.7x

P/S Ratio

-6.0x

P/E Ratio

Is KDAG.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KDAG.F income statement (TTM)
Revenue	CA$215.23k
Cost of Revenue	CA$2.94m
Gross Profit	-CA$2.72m
Other Expenses	CA$5.53m
Earnings	-CA$8.25m

Last Reported Earnings

Jan 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-0.045
Gross Margin	-1,265.29%
Net Profit Margin	-3,835.08%
Debt/Equity Ratio	4.3%

How did KDAG.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/03 21:35
End of Day Share Price	2025/05/01 00:00
Earnings	2025/01/31
Annual Earnings	2024/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

KDA Group Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.